AIGH Capital Management LLC lifted its stake in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) by 7.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,207,009 shares of the company’s stock after buying an additional 155,204 shares during the quarter. scPharmaceuticals makes up about 7.4% of AIGH […]
scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Analysts at Leerink Partnrs issued their FY2027 earnings estimates for scPharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst R. Ruiz expects that the company will earn $2.55 per share for the year. The consensus estimate for scPharmaceuticals’ current full-year […]
Tower Research Capital LLC TRC increased its holdings in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) by 17.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,982 shares of the company’s stock after buying an additional 2,533 shares during the quarter. Tower […]
scPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Analyst Recommendations This is a summary of recent ratings […]
scPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Volatility and Risk scPharmaceuticals has a beta of 0.17, […]